Decline in Sales of E-cigarette Products for Tianchang Group

Business by 2FIRSTS.ai
Jan.15.2024
Decline in Sales of E-cigarette Products for Tianchang Group
Hong Kong-listed company TSC Group (02182.HK) reported an approximate 79% decrease in sales of its e-cigarette products.

Hong Kong stock exchange-listed company Tianchang Group (02182.HK) recently announced that its unaudited operating data for the 11 months ending November 30, 2023, and other relevant information regarding its e-cigarette product division, revealed a decrease of approximately 79% in sales compared to the same period last year. The main reason for the decline was the cancellation of exclusive rights terms in sales orders with customers.

 

Tianchang Group announced its plans to expand its customer base by actively seeking new clients for purchasing high-quality e-cigarette products.

 

According to reports, Tianchang Group is an integrated injection molding solution provider, specializing in mold design and manufacturing services, as well as injection component design and manufacturing services. In recent years, the company has expanded its business to OEM manufacturing of e-cigarette products. Tianchang Group has previously acted as a contract manufacturer (OEM) for the e-cigarette brand "blu" under Imperial Tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration director Zhang Jianmin met with Korean Tobacco Company president Fang Jingwan in Beijing on October 31.
Nov.03 by 2FIRSTS.ai
2025 China Shenzhen Top 500 Enterprises List: 13 E-cigarette Companies Include
2025 China Shenzhen Top 500 Enterprises List: 13 E-cigarette Companies Include
Shenzhen e-commerce companies dominate 2025 Top 500 list, including 13 e-cigarette businesses. Shenzhen FirstUnion Tech climbs 57 spots.
Oct.30 by 2FIRSTS.ai
Smoore: Profit Growth Gradually Improving, Fourth Quarter Shows Promise — A 2Firsts Reader Submission
Smoore: Profit Growth Gradually Improving, Fourth Quarter Shows Promise — A 2Firsts Reader Submission
Smoore released its financial results for the third quarter of 2025.A reader submitted to 2Firsts, noting that Smoore’s declining profit margin was mainly due to the substantial upfront investment in its new heated tobacco products, the relatively low margins of vaping devices, and price reductions resulting from product iterations in the European atomization market.as product structure adjustments near completion, the company’s profit growth is expected to further rebound in the fourth quart.
Oct.13
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma will soon consider a proposal to impose a complete ban on the sale of vapes. The move follows President Vladimir Putin’s endorsement of a nationwide prohibition. Lawmaker Aleksey Volotskov said vape use has surged by 52% since early 2025, with illegal products now dominating 80% of the market.
Nov.11 by 2FIRSTS.ai
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.
Oct.11 by 2FIRSTS.ai
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10